Pre-clinical Data to be Presented at The IASLC 16th World Conference On Lung Cancer
Dublin, Ireland, September 8, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer,...
Pre-clinical Data to be Presented at The IASLC 16th World Conference On Lung Cancer
Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at IWCLL 2015
Inflection Biosciences Shortlisted for Best Emerging Biotech at OBN Awards
Inflection Biosciences Adds Renowned Experts to its Oncology Advisory Panel
Inflection Biosciences Shortlisted for The Pharma Industry Awards 2015
Inflection Biosciences’ Director of R&D Interviewed by Pharma Television
Pre-clinical Data to be Presented at the 20th Congress of the European Hematology Association
Inflection Biosciences to Present at 2015 BIO International Convention
Inflection Biosciences to Present at BioEquity Europe 2015
Inflection Biosciences to Present at BioTrinity 2015